Disposable Blood Bags Market Size, Share, Trend, Outlook, Future Analysis And Synthesis By 2026 Disposable blood bags are the biomedical devices used for collection, storage, transportation, and transfusion of blood and its components. In recent times, disposable plastic blood bags has replaced the usage of glass bottles due to problems associated with use of glass bottles including inadequate sterility, leading to blood contamination, and the presence of air bubbles resulted to severe complications during blood transfusion. Disposable plastic blood bags also help in the separation of blood components such as plasma, platelets, and cryoprecipitate, which are used to treat a range of blood disorders.
The global disposable blood bags market size was valued at US$ 230.1 million in 2017, and is expected to witness a CAGR of 12.1% over the forecast period (2018 – 2026).
Get In-Depth Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/requestsample/2170
Disposable Blood Bags Market - Competitive Landscape Key players operating in the global disposable blood bags market include AdvacarePharma, Fresenius Kabi, Grifols, HLL Lifecare, Haemonetics Corporation, Macopharma, Neomedic, Poly Medicure, SURU International, Span Healthcare, and TERUMO PENPOL. Use of biosafety materials in the manufacturing of blood bags and favorable support from government authorities is expected to create huge growth opportunities for disposable blood bag manufacturers.
Increasing Prevalence of Blood Related Disorders such as Blood Cancer, Anemia, Sickle Cell Disease, Hemophilia, and Other Rare Blood Disorders is Expected to Drive the Disposable Blood Bags Market Revenue
Rising prevalence of diseases such as cancer and various blood related disorder (anemia, hemophilia, and sickle cell disease) is increasing demand for blood transfusion, which eventually drives growth of the disposable blood bags market. For instance, according to Red